This symposium will explore all of the hot topics on use of real-time continuous glucose monitoring (rtCGM), including clinical trial and real-world data, how to interpret the ambulatory glucose profile, and how this technology is advancing diabetes management in all new ways in 2022 and beyond. In addition, experts in diabetes management will assess the burden of CGM device use in patients with type 2 diabetes